Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 1;5(7):e2220986.
doi: 10.1001/jamanetworkopen.2022.20986.

Association Between Expanded Genomic Sequencing Combined With Hearing Screening and Detection of Hearing Loss Among Newborns in a Neonatal Intensive Care Unit

Yunqian Zhu  1 , Liyuan Hu  1 , Lin Yang  2 , Laishuan Wang  1 , Yulan Lu  3 , Xinran Dong  3 , Tiantian Xiao  1 , Zhengmin Xu  4 , Bingbing Wu  3   5   6 , Wenhao Zhou  1   5   6
Affiliations

Association Between Expanded Genomic Sequencing Combined With Hearing Screening and Detection of Hearing Loss Among Newborns in a Neonatal Intensive Care Unit

Yunqian Zhu et al. JAMA Netw Open. .

Abstract

Importance: Hearing loss is a global social burden. Early identification of hearing loss missed by newborn hearing screening tests in the neonatal intensive care unit is crucial.

Objective: To assess the association between expanded genomic sequencing combined with hearing screening and detection of hearing loss as well as improvement in the neonatal intensive care unit.

Design, setting, and participants: This cohort study was performed between August 8, 2016, and December 31, 2020, among 8078 newborns admitted to the neonatal intensive care unit of the Children's Hospital of Fudan University in Shanghai, China. Follow-up for hearing status was performed via telephone interviews between September 1 and November 30, 2021.

Exposures: A hearing screening test and the expanded genomic sequencing targeting 2742 genes were administered to each patient. Those who failed the hearing screening test or had positive genetic findings were referred for diagnostic audiometry at a median of 3 months of age.

Main outcomes and measures: The primary outcome was hearing loss missed by hearing screening test. Secondary outcomes were genetic findings and benefits associated with the expanded genomic sequencing for clinical management of patients in the neonatal intensive care unit.

Results: Of 8078 patients (4666 boys [57.8%]; median age, 6.3 days [IQR, 3.0-12.0 days]), 52 of 240 (21.7%) received a diagnosis of hearing loss. Expanded genomic sequencing combined with hearing screening was associated with a 15.6% increase (7 of 45 patients) in cases of diagnosed hearing loss that were missed by hearing screening. Of the 52 patients with hearing loss, genetic factors were identified for 39 patients (75.0%); GJB2 and SLC26A4 were the most common genes identified. Patients with genetic findings experienced a more severe degree of hearing loss than those without genetic findings (21 profound, 4 severe, 7 moderate, and 7 mild vs 2 severe, 4 moderate, and 7 mild; P = .005), with more bilateral hearing loss (39 of 39 [100%] vs 9 of 13 [69.2%]; P = .003). Clinical management strategies were changed for patients who underwent genomic sequencing combined with hearing screening.

Conclusions and relevance: This study suggests that expanded genomic sequencing combined with hearing screening may be effective at detecting hearing loss among patients in the neonatal intensive care unit.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure.
Figure.. Study Profile and Benefits of Expanded Genomic Sequencing (EGS) Combined With Newborn Hearing Screening (NBHS) Program Associated With Referral, Diagnosis, and Clinical Management
NICU indicates neonatal intensive care unit.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. The Lancet. Hearing loss: an important global health concern. Lancet. 2016;387(10036):2351. doi:10.1016/S0140-6736(16)30777-2 - DOI - PubMed
    1. Erenberg A, Lemons J, Sia C, Trunkel D, Ziring P. Newborn and infant hearing loss: detection and intervention: American Academy of Pediatrics: Task Force on Newborn and Infant Hearing, 1998-1999. Pediatrics. 1999;103(2):527-530. doi:10.1542/peds.103.2.527 - DOI - PubMed
    1. DiStefano MT, Hemphill SE, Oza AM, et al. ; ClinGen Hearing Loss Clinical Domain Working Group . ClinGen expert clinical validity curation of 164 hearing loss gene-disease pairs. Genet Med. 2019;21(10):2239-2247. doi:10.1038/s41436-019-0487-0 - DOI - PMC - PubMed
    1. Wilson BS, Tucci DL, O’Donoghue GM, Merson MH, Frankish H. A Lancet commission to address the global burden of hearing loss. Lancet. 2019;393(10186):2106-2108. doi:10.1016/S0140-6736(19)30484-2 - DOI - PubMed
    1. The Lancet. Hearing loss: time for sound action. Lancet. 2017;390(10111):2414. doi:10.1016/S0140-6736(17)33097-0 - DOI - PubMed